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Editorial on the Research Topic
Nano- and Microparticle-Induced Cell Death, Inflammation and Immune Responses
INTRODUCTION
Crystals, fibers, and other microparticles form inside the body from nutrients or metabolites but
also enter the body from outside during environmental or occupational exposures. Altogether
crystal and microparticle-related diseases account for numerous medical disorders (1). In some
of these disorders, the crystal masses themselves cause the problem, e.g., when stones obstruct the
bile ducts or the urinary draining system. In other crystal-immune responses largely account for
clinical symptoms and tissue damage, e.g., in gout, silicosis, or asbestosis. This Research Topic
in Frontiers of Immunology selected a series of articles focusing on how immune and tissue cells
respond to crystals, microparticles, and nanoparticles. Our authors shed light on the recent and
ongoing research efforts to unravel the molecular mechanisms underlying particle-related tissue
injury, inflammation, and remodeling. We hope the readers of this Research Topic find the
content useful to further develop the field, to identify common and particle-specific mechanisms
of crystallopathies.
NANO- AND MICROPARTICLE-INDUCED CELL DEATH
Nano- and microparticles induce a broad range of cellular responses when exposed to immune
and non-immune cells. These crystalline particles could be either of environmental origin e.g.,
silica, asbestos, air pollutants, or biological origin e.g., cholesterol, calcium, and monosodium urate
(MSU) crystals.
In the current issue, Shu and Shi gave a systematic overview of the physical and chemical
properties of solid particles and their host responses. For example, phagocytosis of solid particles is
mainly governed by their size, which regulates the inflammatory and cell death responses. Crystals
with sharp and pointy edges induce direct injury as compared to spherical crystals and rod-shaped
crystals. Accordingly, Köppert et al. also found that primary calciprotein particles, which are
spherical, amorphous and soft, were rapidly cleared by liver sinusoidal endothelial cells, whereas
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secondary calciprotein particles, which are longer, more
crystalline, and less soluble, are cleared by Kupffer cells
and macrophages.
Cytotoxicity of crystals mainly involves lysosomal
rupture, activation of multiple cathepsins, mitochondrial
dysfunction leading to either apoptosis or regulated necrosis—
viz. mitochondria permeability transition-related necrosis,
necroptosis, and pyroptosis (Shu and Shi). In addition, MSU was
reported to activate Syk and Src pathways leading to cell death
and inflammation in phagocytosis-independent manner (Shu
and Shi). Similarly, Shu et al. demonstrated that microscopic
cholesterol crystals extract cholesterol from the cell surface
upon physical interactions with the plasma membrane, which
results in catastrophic plasma membrane rupture and necrosis
independent of any known cell death-inducing pathway.
Furthermore, in response to stress, a self-cannibalization process
termed autophagy is activated, which might be associated with
cell death. Frauscher et al. demonstrated that uremia-induced
autophagy in vascular smooth muscle cells protects from
vascular calcification. Interestingly, pharmacological activation
of autophagy protected mice from vascular calcification during
chronic kidney disease (CKD).
Ingestion of nano- and microparticles occurs as
environmental or occupational pollutants, as well as when
used as adjuvants or drug delivery systems. The first line
of immune defense—neutrophils regulate immune response
to these ingested foreign particles either by removing them
by phagocytosis or immobilizing them by trapping with
neutrophils extracellular traps (NETs). Silica nanoparticles when
ingested during pregnancy cause pregnancy complications.
Higashisaka et al. have highlighted the protective roles of
neutrophils during pregnancy complications in a murine
model of pregnancy. They observed that neutrophil depletion
exacerbated silica nanoparticles-induced impairment
of placental vessels and increased apoptotic cell death
during pregnancy.
NANO- AND MICROPARTICLE-INDUCED
INFLAMMATION
A wide range of solid particles is known to induce the formation
of NETs (2), which results in the release of intracellular
danger associatedmolecular patterns to initiate the inflammatory
response. Bilyy et al. demonstrated that agglomerations of non-
stabilized superparamagnetic iron oxide nanoparticles (SPIONs)
induce NET formation both in vivo and in vitro. Interestingly,
they observed that inert coating of SPIONs with biocompatible
albumin or dextran reduced agglomeration and NET formation
by neutrophils and prevented vascular occlusion in vivo. These
findings again confirm that the physical and chemical properties
of solid particles drive host response (Shu and Shi).
At their discovery NETs were considered effective weapons
aimed to capture, immobilize, and kill bacteria. Later the
list of targets was extended to fungi, viruses, and further
pathogens. Recent discoveries have clearly demonstrated that
nano-and microparticulate matter is also prone to stimulate
NETs formation. The minireview of Li et al. summarizes findings
related to NETs formation upon the contact of neutrophils
with crystals from MSU, calcium pyrophosphate dihydrate,
cholesterol, as well as calcium carbonate and silica. Hydrophobic
nanoparticles cause NET formation bymembrane disruption and
lysosomal leakage. However, for some micro- and nanoparticles
the mechanisms of action for the formation of NETs still
remains elusive.
Nanocrystals e.g., those from MSU or cholesterol are prone
to cluster cell surface receptors to trigger cellular responses. The
inhibitory receptors for MSU-induced inflammation CLEC12A
and SIRL-1, are thoroughly discussed in the minireview of
Fernandes and Naccache. The data suggest that interaction
with receptor not only induces mechanical grouping of these
cell surface molecules but initiate more complex regulatory
processes with distinct effects on leukocyte activation. Targeting
inhibitory receptors is a potential therapeutic option to evaluate
existing drugs and future drug candidates. However, the list of
nanoparticles triggering NET formation can be quite exotic, and
very selective.
Cristobalite, contained in volcanic ashes (but not other
ash components), was identified as a trigger in macrophages
of NLRP3 inflammasome activation with subsequent release
of IL-1β (Damby et al.). Inflammasome activation through
inhalation of volcanic ash again links air-born microparticles
with neutrophil activation and pulmonary diseases. Interestingly,
cellular uptake of ash results in lysosomal destabilization, as was
reported earlier size dependently for 10 nm diamonds (3), and is
followed by activation of mitochondrial responses provoking an
oxidative burst.
Calcium oxalate crystals are the naturally occurring particles
that reportedly trigger the formation of NETs. Unfortunately,
many natural inhibitors of crystal formation like nephrocalcin,
osteopontin, uropontin often fail to stop pathological crystal
deposition during CKD. The disease is accompanied by fibrosis
largely mediated by Transforming Growth Factor beta (TGFβ),
and thus anti-TGFβ antibodies are widely used in treatment.
Steiger et al. proposed that antibodies can also bind some calcium
compounds and thus slow down the process of crystallization
in the affected organ. They demonstrated that anti-TGFβ IgG
ameliorates CKD not only directly via its influence on the target
but also by the prevention of the formation of calcium oxalate
crystals in the affected kidneys.
Calcium oxalate nanoparticles were also found to activate
human monocyte and enhance local tissue inflammatory
responses governed by the production of TNF-a, IL-1b, IL-8,
and IL-10. Contact with calcium oxalate crystals but not with
zinc oxide nanoparticles stimulated macrophage differentiation
into the inflammatory M1-type (Dominguez-Gutierrez et al.). In
addition, the properties of a putative calcium oxalate receptor are
discussed in the paper.
Another natural defense mechanism against nanoparticles
was reported in the work (Marschner et al.), where long pong
pentraxin 3 (PTX3), an opsonin known to interact with dead
cells and other extracellular microparticles, was identified as
an endogenous factor inhibiting growth of calcium oxalate
crystals. By limited CaOx crystal aggregation and adhesion to
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tubular cell membranes it serves as one of several endogenous
inhibitors of stone formation in nephrocalcinosis and potentially
other crystallopathies.
NANO- AND MICROPARTICLE-INDUCED
IMMUNE RESPONSES
When it comes to immune response the first task of the
immune system is to recognize the invader, and micro-
and nanoparticles are hard to be recognized, since usually
they are the same compounds the body encounters daily in
smaller concentrations or in a different soluble form (e.g.,
MSU). The review of Nakayama summarizes recent advances
in our understanding how macrophages recognize crystals
particles: some crystal particles are negatively charged and
are recognized by scavenger receptor family members in a
charge-dependent manner. Alternatively, a model for receptor-
independent phagocytosis of crystals has also been proposed to
explain their clearance by macrophages (Mahon and Dunnet).
Effect of the nanoparticle engulfment can be quite different. Silver
and gold nanoparticles when covered with tannic were able to
induce maturation of dendritic cells and stimulate the uptake of
viral particles (HCV-2) (Orlowski et al.).
Unfortunately, there are much more of them causing harmful
effects. The minireview by Mahon and Dunne summarize the
role of particles associated with gout, calcium pyrophosphate
deposition (CPPD) disease, and osteoarthritis (OA). As well as
wear-debris particles generated from prosthetic implants and
contributing to joint destruction through the production of
cartilage-degrading enzymes and pro-inflammatory cytokines,
driving periprosthetic osteolysis which impacts on the longevity
of total joint replacements. Understanding the danger of
implantedmaterial will allow us to better definemolecular targets
to inhibiting side effects of implantation-associated dangerous
micro and nanoparticles (Chulpanova et al.; Orlowski et al.).
Some nanoparticles like silica are known for decades to cause
disease and autoimmune disorder, but it is not that easy to
study the conditions in experimental setup due to the fact that
most established animal (mice) cell line are prone to develop
only a part of the whole repertoire of interactions attributable
to autoimmune conditions in human. In the work of Mayeux et
al. this limitation was overcome by in-depth analysis of diversity
outbred mice, revealing not only association of silicosis with
lung autoimmunemarkers, bronchoalveolar lavage fluid cells, IL-
6 and anti-ENA5, but also stronger silica-induced inflammation
between mal mice. We should remember that cellular remnants
and “apoptotic blebs” are also of nano- and microscale, and
usually engulfment is silent and anti-inflammatory process
(Tucher et al.). Apoptotic cells were known to produce different
type of micro and nano extracellular vesicles (EV) they were
known to be differently glycosylated and distinctly processed
by macrophages (4). However, the formation of nanoparticles,
like exosomes and others extracellular vesicles not related to
apoptosis make their discrimination complicated. Group of
Schiller have demonstrated that protein composition of apoptotic
EV is quite unique and thus can serve as reliable discrimination
factor; some danger signals like HMGB1 protein could be found
only in apoptotic-related microvesicles (Tucher et al.). Another
important finding suggests that release of large extracellular
vesicles, 200 to 1,000 nm in diameter, involve proteasome action
(Tucher et al.).
But when it comes to cancer, it looks that EV are becoming
powerful communicating and instructing tools. In minireview
“Role of macrovesicles produced by cancer cells,” immune
cells and mesenchymal stem cells are discussed in details,
demonstrating how modification of the extracellular vesicle
cargo can target specific tumor mechanisms responsible for
tumor formation and progression to develop new therapeutic
strategies and to increase the efficacy of antitumor therapies
(Chulpanova et al.).
Immunosuppression is a key factor in silent clearance of
dying cell microdebris, thus it’s role in dealing with disease
associated nano- and micro particles is crucial. The review
by Huaux details the contribution of immunosuppressive
cells and their derived immunoregulatory mediators and
discusses the role of inflammatory vs. immunosuppressive
mechanisms connecting micro- and nano-particles with
pathogenesis of chronic diseases. The review summarizes role of
immunosuppressive cytokines, involvement of regulatory T- and
B lymphocytes, immunosuppressive myeloid cells and discusses
how particle-related diseases can develop independently of
chronic inflammation, enriches current bioassays predicting
particle toxicity and suggests new clinical strategies for
treating patients affected by particle-associated diseases
(Marschner et al.).
PERSPECTIVES
The studies of this issue illustrate that crystals and microparticles
induce diverse biological responses beyond triggering the NLRP3
inflammasome and the secretion of IL-1β from myeloid cells
(5). Crystal biology just started as an interdisciplinary field
and certainly holds bright promises for major discoveries also
in the future. We still do not understand the full spectrum
of molecular mechanisms shared across particles of different
natures as well as different sizes and shapes. Often molecular
machinery prone to recognize cellular debris can also react with
inorganic crystals and vice versa. We lack an understanding
of the particle-specific immune responses. Another unsolved
issue is the functional differences between microparticle-induced
neutrophil necroptosis and NET formation, a regulated form
of chromatin release different from regulated neutrophil
necrosis (6, 7). Only an interdisciplinary approach can
address these important questions and eventually lead to
new treatment modalities for patients with crystal- and
microparticle-related disorders.
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